Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Transitional cell carcinoma of the bladder associated with cyclophosphamide.

Dale GA, Smith RB.

J Urol. 1974 Nov;112(5):603-4. No abstract available.

PMID:
4214370
2.

Bladder cancer following administration of cyclophosphamide.

Durkee C, Benson R Jr.

Urology. 1980 Aug;16(2):145-8.

PMID:
6250267
3.

[Tumors of the upper urothelium and cyclophosphamide: presentation of a case and review of the literature].

de Castro Barbosa F, Rosell Costa D, Agüera Fernández L, Isa Kroon WA, Sánchez de la Muela P, Robles García JE, Zudaire Bergera JJ, Berián Polo JM.

Arch Esp Urol. 1991 Dec;44(10):1149-51. Review. Spanish.

PMID:
1817448
4.

Bladder cancer after cyclophosphamide therapy for lupus nephritis.

Ortiz A, Gonzalez-Parra E, Alvarez-Costa G, Egido J.

Nephron. 1992;60(3):378-9. No abstract available.

PMID:
1565199
5.

Cyclophosphamide-induced urinary bladder cancer: a case report.

Shuin T, Kubota Y.

Jpn J Clin Oncol. 1983 Mar;13(1):75-80. No abstract available.

PMID:
6834654
6.

Cyclophosphamide-induced transitional cell carcinoma of bladder in lupus nephritis.

Chow SK, Looi LM, Loh CS, Yeap SS.

Intern Med J. 2002 Mar;32(3):114-6. No abstract available.

PMID:
11885838
7.

[Bladder carcinoma in a case of multiple myeloma IgG (kappa) treated with cyclophosphamide: review of literature].

Iwabuchi A, Hohjoh H, Fujieda H, Ohyashiki J, Ohyashiki K, Toyama K.

Rinsho Ketsueki. 1988 Aug;29(8):1272-6. Review. Japanese. No abstract available.

PMID:
3144618
8.

Letter: Cyclophosphamide.

Weinstein SH, Milleman LA, Schmidt JD.

J Urol. 1975 Jul;114(1):157. No abstract available.

PMID:
1142491
9.

Cyclophosphamide and carcinoma of bladder.

Seltzer SE, Benazzi RB, Kearney GP.

Urology. 1978 Apr;11(4):352-6.

PMID:
664141
10.

Cyclophosphamide and the bladder.

Worth PH.

Br Med J. 1971 Jul 17;3(5767):182. No abstract available.

11.

Bladder complications in patients receiving cyclophosphamide for systemic lupus erythematosus or rheumatoid arthritis.

Plotz PH, Klippel JH, Decker JL, Grauman D, Wolff B, Brown BC, Rutt G.

Ann Intern Med. 1979 Aug;91(2):221-3.

PMID:
464465
12.

Urological complications of cyclophosphamide.

Levine LA, Richie JP.

J Urol. 1989 May;141(5):1063-9. Review. No abstract available.

PMID:
2651710
13.

Bladder carcinoma following cyclophosphamide therapy. A case report.

Kiesswetter H, Baloch N, Flamm J.

Int Urol Nephrol. 1985;17(2):139-42.

PMID:
4086230
14.
15.

Urothelial carcinoma after cyclophosphamide therapy.

Moinuddin SM, Upton DW.

J Urol. 1983 Jan;129(1):143-4.

PMID:
6827670
16.

The effects of cyclophosphamide treatment on the epithelium and stroma of the urinary bladder.

Beyer-Boon ME, de Voogt HJ, Schaberg A.

Eur J Cancer. 1978 Oct;14(10):1029-35. No abstract available.

PMID:
710474
17.

Cyclophosphamide-induced cystitis and bladder cancer in patients with Wegener granulomatosis.

Talar-Williams C, Hijazi YM, Walther MM, Linehan WM, Hallahan CW, Lubensky I, Kerr GS, Hoffman GS, Fauci AS, Sneller MC.

Ann Intern Med. 1996 Mar 1;124(5):477-84.

PMID:
8602705
18.

[Urothelial cancers from Endoxan].

Dumas JP, Roulet B, Colombeau P, Loubet R.

J Urol (Paris). 1984;90(6):411-2. French.

PMID:
6520414
19.

[Bladder neoplasms and cyclophosphamide. Apropos pf 3 cases amd review of the literature].

Alexandre J, Lévy V, Hunault M, Bazarbachi A, Delmer A, Rio B, Zittoun R.

Bull Cancer. 1996 Nov;83(11):945-50. Review. French.

PMID:
9033605
20.

Cyclophosphamide-associated carcinoma of urothelium: modalities for prevention.

Cannon J, Linke CA, Cos LR.

Urology. 1991 Nov;38(5):413-6.

PMID:
1949449

Supplemental Content

Support Center